Rankings
▼
Calendar
BDX
Becton, Dickinson and Company
$59B
Q4 2019 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$4.6B
+4.1% YoY
Gross Profit
$2.3B
49.4% margin
Operating Income
$111M
2.4% margin
Net Income
$162M
3.5% margin
EPS (Diluted)
$0.41
QoQ Revenue Growth
+5.4%
Cash Flow
Operating Cash Flow
$1.4B
Free Cash Flow
$1.0B
Stock-Based Comp.
$53M
Balance Sheet
Total Assets
$51.8B
Total Liabilities
$30.7B
Stockholders' Equity
$21.1B
Cash & Equivalents
$536M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.6B
$4.4B
+4.1%
Gross Profit
$2.3B
$2.1B
+8.4%
Operating Income
$111M
$571M
-80.6%
Net Income
$162M
-$135M
+220.0%
Revenue Segments
Medical
$2.4B
53%
Life Sciences
$1.1B
25%
Interventional
$1.0B
22%
Geographic Segments
UNITED STATES
$2.6B
56%
Non-US
$2.0B
44%
← FY 2019
All Quarters
Q1 2020 →
BDX Q4 2019 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena